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ABSTRACT: Diblock copolymer vesicles are tagged with pH-
responsive Nile Blue-based labels and used as a new type of
pH-responsive colorimetric/ﬂuorescent biosensor for far-red
and near-infrared imaging of live cells. The diblock copolymer
vesic les descr ibed herein are based on poly(2-
(methacryloyloxy)ethyl phosphorylcholine-block-2-
(diisopropylamino)ethyl methacrylate) [PMPC-PDPA]: the
biomimetic PMPC block is known to facilitate rapid cell
uptake for a wide range of cell lines, while the PDPA block
constitutes the pH-responsive component that enables facile vesicle self-assembly in aqueous solution. These biocompatible
vesicles can be utilized to detect interstitial hypoxic/acidic regions in a tumor model via a pH-dependent colorimetric shift. In
addition, they are also useful for selective intracellular staining of lysosomes and early endosomes via subtle changes in
ﬂuorescence emission. Such nanoparticles combine eﬃcient cellular uptake with a pH-responsive Nile Blue dye label to produce
a highly versatile dual capability probe. This is in marked contrast to small molecule dyes, which are usually poorly uptaken by
cells, frequently exhibit cytotoxicity, and are characterized by intracellular distributions invariably dictated by their hydrophilic/
hydrophobic balance.
■ INTRODUCTION
Fluorescent probes are widely used for imaging in cell biology.
Increasingly, they are also being utilized as chemosensors to
diagnose speciﬁc pathological conditions and report on cellular
events.1−3 There is considerable interest in designing nano-
particles that report on physiologically relevant species such as
ions,4−6 reactive oxygen species,7−9 gaseous biological second
messengers10−12 and hydrogen ions.9,13,14 In particular, pH
probes have diagnostic potential because many diseases are
associated with changes in the local pH.15 These include clinical
and subclinical inﬂammation,16 many lung-related patholo-
gies,17 kidney dysfunction,18 ischemia,19 and cancer.20 In
malignant tumors, the interstitial pH is lower than in normal
tissue, and this parameter can be correlated with both poorer
prognosis and weaker responses to available therapies.21,22 This
lower interstitial pH is a result of increased lactic acid
production and reduced buﬀering and perfusion,23 while the
intracellular pH of the tumor cells typically remains at
physiological levels.24−26 Monitoring changes in the interstitial
ﬂuid within tumors is a major challenge, as most of the available
probes penetrate cells and therefore only report the intracellular
pH. Additional concerns associated with diagnostic probes are
toxicity, targeting speciﬁcity, and signal-to-noise threshold.27
For example, ﬂuorescence spectroscopy and imaging are
normally considered to be highly sensitive techniques, with
extremely low detection limits being achieved under ideal
conditions.28 However, such sensitivity may be substantially
reduced in vivo, particularly if the emission spectrum of the
selected ﬂuorophore overlaps with that of the living tissue.
Thus there is considerable interest in designing new ﬂuorescent
probes based on dyes that emit in the far-red end of the visible
spectrum, i.e. above 600−700 nm, in order to minimize such
background interference.29 Due to lower background interfer-
ence, far red and infrared light can penetrate much more deeply
into living tissue, which is beneﬁcial for in vivo studies.30,31
Herein we describe a facile method for labeling polymers
prepared by controlled radical polymerization techniques (e.g.,
atom transfer radical polymerization (ATRP) or reversible
addition−fragmentation chain transfer (RAFT) polymeriza-
tion) by reaction with Nile Blue-based dyes, which are found to
act as polymerization spin traps.
This labeling principle was used to prepare nanoparticle-
based pH sensors composed of a pH-sensitive dye label and a
biocompatible pH-responsive diblock copolymer based on (2-
(methacryloyloxy)ethyl phosphorylcholine) [MPC] and 2-
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(diisopropylamino)ethyl methacrylate [DPA].32,33 PMPC-
based nanoparticles have been previously shown to penetrate
tumors with high eﬃciency.34 In addition, they can be rapidly
incorporated into many diﬀerent cell types and are distributed
inside intracellular organelles.35,36 The pH-sensitive probe is
based on Nile Blue. Both the absorption and emission
properties of Nile Blue derivatives are found to be pH-sensitive
at around physiological pH.
These new nanoparticle probes report clinically relevant pH
changes in tumors and cell organelles, thus enabling pH sensing
both at the interstitial level (as demonstrated with multicell
tumor spheroids) and also at the subcellular level.
■ RESULTS AND DISCUSSION
Synthesis of Nile Blue Dye Derivatives. The synthesis of
the Nile Blue methacrylamide (NBM) and Nile Blue 2-
(methacryloyloxy)ethyl carbamate (NBC) monomers used in
this work is summarized in Scheme 1. Both monomers have
been previously prepared by similar synthetic routes.37,38 These
methacrylic dyes were used as prepared for copolymerizations,
but were further puriﬁed using column chromatography in
order to assess their spectroscopic properties (Table S1 of the
Supporting Information, SI). Dye purity before and after
column chromatography was assessed using HPLC (Table S1
of the SI). Each monomer was characterized by absorption
spectroscopy studies in ethanol (Table S1 and Figure S1 of the
SI). Both the absorption coeﬃcient at λmax and the integral
absorption coeﬃcient39 were determined for each dye label and
found to be close to the values measured for a commercially
available Nile Blue dye precursor (95% purity, laser grade),
which suggests high purities for these Nile Blue-based
monomers (Table S1 of the SI).
Dye-Labeling of PMPC. In initial experiments, it was
found that statistical copolymerization of MPC with small
quantities of either NBC, NBM, or NB via Atom Transfer
Radical Polymerization (ATRP) aﬀorded dye-labeled copoly-
mers with somewhat lower dye contents than those targeted
(Table S2 of the SI). This protocol also signiﬁcantly retarded
the overall rate of copolymerization (Figure S2 of the SI).
Similar retardation/inhibition was also observed when attempt-
ing to copolymerize NBM and NBC using reversible addition−
fragmentation chain transfer (RAFT) polymerization (Figure
S3 of the SI). With the beneﬁt of hindsight, Nile Blue is
structurally similar to well-known polymerization inhibitors
such as methylene blue or phenothiazine (Figure S4 of the SI).
Thus it seems that these Nile Blue derivatives act as spin traps
during their copolymerization with MPC, leading to retardation
eﬀects (Figure S5 of the SI).40 We hypothesized that well-
deﬁned Nile Blue-labeled polymers could be conveniently
prepared by reacting Nile Blue with the propagating polymer
radicals, thus quenching the polymerization and leading to a
terminally attached dye label (see Figure S5 A, eq 7 of the SI).
This hypothesis is supported by literature data for the reaction
of phenothiazine and related compounds with alkyl radicals.41
This suggests that the rate of reaction between alkyl radicals
and vinyl monomers is at least as fast (or faster) as that
between alkyl radicals and phenothiazine-like compounds. On
the basis of the results described in ref 41 and also data
obtained for the polymerization of aniline42 the quenched
polymer chain is most likely conjugated to the Nile Blue via its
iminium nitrogen (see Figure S5B of the SI), but further
mechanistic details are beyond the scope of the present study.
For NBM, reaction with the double bond seems likely, which
would produce a persistent radical that is stabilized via
conjugation. For NBC, reaction with the double bond could
lead to an intramolecular reaction with the aromatic ring,
leading to a stabilized radical. Thus Nile Blue precursor was
added to a MPC homopolymerization at a monomer conversion
of around 70−80% (Table S2, entry 7 of the SI). This protocol
minimizes the problem of retardation and hence improves the
overall yield: the dye label reacted with 8% of the PMPC
chains, which were of relatively low polydispersity. The NBM
and NBC comonomers were also added to separate MPC
homopolymerizations at similarly high conversions (see Table
S2, entries 5 and 6, respectively, of the SI). In these latter
syntheses, the dye label can be incorporated via copolymeriza-
Scheme 1. Synthesis of Two Nile Blue-Based Vinyl Monomers Used in This Worka
aNile Blue methacrylamide (NBM) and Nile Blue 2-(methacryloyloxy)ethyl carbamate (NBC).
Scheme 2. Deprotonation of (a) NB, (b) NBM, and (c)
NBCa
aThe monocationic form of Nile Blue is stabilized by resonance,
thereby increasing its pKa to around 10. In contrast, NBM and NBC
cannot form such resonance structures, thus their pKa values are
correspondingly lower.
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tion, as well as acting as a chain transfer agent. Thus the ﬁnal
dye contents were slightly higher when using NBM and NBC,
compared to that achieved for Nile Blue alone (compare entries
5, 6, and 7 in Table S2 of the SI). However, the conjugated dye
content never exceeded 16 mol % of the added dye, so
extensive dialysis was required to remove non-conjugated dye
(see SI).
Furthermore, the rate of ATRP or RAFT copolymerization
decreases in the presence of each Nile Blue monomer (Figures
S2 and S3 of the SI) and no signiﬁcant increase in monomer
conversion was found by 1H NMR spectroscopy when the dye
was added at high conversion (data not shown). These
observations suggest that all three vinyl-functional dyes actually
act mainly as chain transfer agents, rather than as comonomers.
Absorption and Emission Properties of Dye-Labeled
PMPC Homopolymers. The maximum emission wavelength
of all labeled PMPC homopolymers in PBS at pH 7.2 was
within 20 nm of 674 nm, the literature value reported for Nile
Blue (Table S2 of the SI).43 However, the maximum absorption
wavelength shifted to around 590 nm for homopolymers
labeled with NBM and NBC. In contrast, homopolymers
terminated using unmodiﬁed Nile Blue precursor had a
maximum absorption wavelength close to 650 nm in PBS.
(Table S2 and Figure S7 of the SI). Relative quantum yields
Scheme 3. Atom Transfer Radical Polymerization (ATRP) Synthesis of PMPC-PDPA Diblock Copolymers Terminated with
Either Nile Blue (NB) Alone or Containing a Nile Blue-Based Comonomer (Either NBM or NBC)a
aIn each synthesis, the Nile Blue-based reagent was added after approximately 80% conversion of the DPA monomer, as judged by 1H NMR
spectroscopy.
Figure 1. Visible absorption characteristics of three PMPC25PDPA59NBC0.08, PMPC25PDPA62NBM0.13 and PMPC25PDPA61NB0.13 diblock
copolymers as a function of pH. (a) Digital photographs obtained for 5 mg/mL aqueous copolymer solutions in 1 cm cuvette cells. (b) Variation of
λmax with solution pH. (c) Absorption spectra recorded at pH 5. (d) Absorption spectra recorded at pH 6. (e) Absorption spectra recorded at pH 7.
Spectrometer settings: Scan speed = 200 nm min−1; bandwidth = 1.5 nm.
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were determined for all Nile Blue-labeled homopolymers in
PBS at pH 7.2 (Table S2 of the SI). NBM-labeled chains had
relatively low quantum yields, comparable to that of Nile Blue.
However, Nile Blue-terminated PMPC chains generally gave
higher quantum yields. This agrees with previous literature
reports suggesting that solubilizing groups (in this case the
PMPC chain) suppress dye aggregation in aqueous solu-
tion.43,44 If NBC was used as a comonomer, then relative
quantum yields are generally one order of magnitude greater
than for Nile Blue (Table S2 of the SI). Similarly high quantum
yields have been reported for deprotonated Nile Blue (Scheme
2).45
The pH-dependent ﬂuorescence of dye-labeled PMPC
homopolymers was examined (see Figures S8 and S9 of the
SI). Chains labeled with unmodiﬁed Nile Blue exhibited a low
emission intensity below pH 3, and enhanced emission above
pH 8. Stronger emission in alkaline solution suggests
deprotonation of the Nile Blue (see Scheme 2a).46 Reduced
emission observed in acidic solution is most likely related to
protonation of Nile Blue at the second nitrogen on the ring.47
As shown in Scheme 2a, monocationic Nile Blue is resonance-
stabilized, which accounts for its unusually high pKa compared
to other aromatic amines such as aniline.48 The ﬂuorescence
behavior of the PMPC homopolymers labeled with either NBM
or NBC exhibits pH-sensitivity in the physiological region
(Figures S8 and S9 of the SI). Below pH 6, a single emission
band was observed at 670 nm for PMPC41NBM0.16. Above pH
6, a new band appeared at around 700 nm. The 700/670 nm
emission intensity ratio increased signiﬁcantly at higher pH for
PMPC41-NBM0.18, whereas this ratio remained essentially
constant for PMPC chains labeled with either NB or NBC
(Figure S9 of the SI). In contrast, the integrated emission
intensity of PMPC41NBC0.10 increased by one order of
magnitude between pH 5 and pH 8 (Figure S9 of the SI).
This strongly enhanced emission is consistent with the higher
quantum yields found for this particular polymer (Table S2 of
the SI). Studies of lipophilic Nile Blue derivatives with chemical
structures similar to NBM and NBC have reported lower pKa
values than for nonmodiﬁed Nile Blue.49 This is probably due
to the electron-withdrawing eﬀect of the carbonyl substituent
on the imine nitrogen, which destabilizes the monocationic
derivatives relative to unmodiﬁed Nile Blue. Such destabiliza-
tion leads to lower pKa values that are comparable to those
found for other aromatic amines such as aniline48 (see Scheme
2).
The spectral changes observed for PMPC chains labeled with
NBM and NBC occur at slightly lower pH values compared to
those found for the NBM and NBC monomers (Figures S9 and
S10 of the SI). Moreover, the ﬂuorescence intensity of the
labeled homopolymers increases at higher pH. This is in
Figure 2. (a) Ultralow attachment 96-well plate model for the growth of multicellular tumor spheroids (MCTS), which were exposed to 1.0 g/L Nile
Blue labeled PMPC-PDPA diblock copolymers for 36 h and corresponding digital photographs recorded for two wells containing 15-day-old MCTS
after exposure to the copolymer nanoparticles for 36 h. (b) pH-Dependent staining of MCTS by Nile Blue-labeled PMPC-PDPA copolymers.
Bright-ﬁeld optical images of Nile Blue-labeled copolymer-treated MCTS and controls were recorded using a Leica DMI4000B instrument equipped
with a Nuance Multispectral imaging System. Untreated control spheroids were used to subtract the background noise from these images. Image
analysis was performed double-blinded. Four independent observers were asked to score the center of the tumor (white star), the edge (red dotted
line) and whether the observer could identify the boundary for the color change (black dotted line). Hypoxic (low pH) regions of the spheroids were
compared to a positive control marker for hypoxia (Glut-1 immunostaining).
Figure 3. Monitoring the reduction in local pH within multicellular
tumor spheroids (MCTS) over time using Nile Blue-labeled PMPC-
PDPA diblock copolymer vesicles. MDA-MB-231 breast tumor
spheroids were grown on ultralow adhesion 96-well plates. These
MCTS samples were treated with 1.0 g/L of PMPC-PDPA vesicles for
36 h and then imaged using an optical microscope (Leica Caliper LS,
20X, which corresponds to approximately 25% of the total area of an
MCTS). Micrographs were analyzed de viso (see Figure 2b) and the
radii of the hypoxic (blue, acidic) areas of the spheroids were
compared to the overall MCTS radii. The hypoxic/tumor radius ratio
was monitored over time for 5, 10, or 15 days. Immunolabeling of
Glut-1 was used as a control for ﬁxed spheroid hypoxia. Data are
expressed as mean radius ratios for N = 3 independent experiments ±
SEM.
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striking contrast to the behavior of the corresponding
monomers, for which a reduction in intensity is observed at
higher pH. However, the deprotonated forms of NBM and
NBC are stabilized in aqueous solution when conjugated to a
highly hydrophilic PMPC chain, which explains the lower pH
transition. In contrast, the corresponding deprotonated
monomers have relatively low aqueous solubilities, similar to
what has previously been observed for structurally related
lipophilic Nile Blue derivatives.49 Therefore, the polymerized
ﬂuorophores are signiﬁcantly more ﬂuorescent in aqueous
solution than their vinyl monomer counterparts (Figure S9 of
the SI)
Dye-Labeled PMPC-PDPA Diblock Copolymers.
Although the pH-sensitive emission of the labeled homopol-
ymers occurs within a pH range that is physiologically relevant,
PMPC homopolymers do not enter cells (Figure S11 of the
SI).50 Therefore, in order to exploit this unexpected pH-
dependence, three pH-responsive PMPC-PDPA diblock
copolymers32 were prepared using either NB, NBC, or NBM
(Scheme 3). In each case, the PMPC block was used as a
macroinitiator and the dye label was added at relatively high
DPA conversion (around 80%). Vesicle-forming pH-responsive
PMPC-PDPA diblock copolymers with similar compositions
have been previously used for both in vitro and in vivo drug
delivery.33−35,51,52 The eﬀect of varying the solution pH on the
absorption of the three labeled pH-responsive diblock
copolymers is shown in Figure 1. Raising the pH did not
lead to a signiﬁcant change in the color of the PMPC25-
PDPA61-NB0.13 solution/dispersion up to pH 9, whereas a
distinct color change from blue to purple was observed between
pH 5 and 6 for PMPC25PDPA59NBC0.08 and between pH 6 and
7 for PMPC25PDPA62NBM0.13 (Figure 1a). Deprotonation of
the PDPA block, which occurs just above pH 6, leads to in situ
self-assembly to form diblock copolymer vesicles.32 The vesicle
membranes comprise PDPA chains, which provide a highly
hydrophobic environment that shifts the absorption wavelength
of the Nile Blue label and increases its quantum yield.41,43
Figure 1b shows how λmax varies with pH for all three
copolymers. The λmax observed for PMPC25PDPA61NB0.13
decreases sharply from 640 to 585 nm between pH 6.0 and
pH 6.4. This pH range corresponds approximately to the
known pKa of the PDPA block.
32 Close examination of the
Figure 4. (a) Fluorescence intensity vs pH for 1.0 g/L aqueous solutions of Nile Blue-labeled PMPC-PDPA diblock copolymers recorded at an
excitation wavelength of 550 nm. (b) Fluorescence emission intensity ratio (700/670 nm; excitation wavelength = 550 nm) vs pH for 1.0 g/L
aqueous solutions of Nile Blue-labeled PMPC-PDPA copolymers. (c) Subcellular ﬂuorescent staining of organelles in live cells by Nile blue-labeled
PMPC-PDPA copolymers. Primary human dermal ﬁbroblasts were treated with a 1.0 g/L aqueous solution of each of the three copolymers for 24 h.
Fluorescence micrographs were recorded to identify the subcellular signal of the copolymers (λex (550 nm)/λem (670 nm); λem = 700 nm). Each
copolymer signal was colocalized with the following conventional subcellular markers: early endosome marker for Rab-5 (CellLight Early
Endosomes-GFP, Invitrogen) and lysosomal marker (Lysotracker, Invitrogen). The amphiphilic PMPC-PDPA diblock copolymer diﬀuses
throughout the subcellular region, but accumulates preferentially at membrane surfaces. The local pH of the lysosomes is below pH 5, whereas the
local pH of the early endosomes is around pH 6−7. Thus the two Nile Blue comonomer labels report both the presence and the chemical state of
the copolymer, with the latter being sensitive to the local pH due to the pH-responsive nature of the PDPA block. In contrast, if the Nile Blue label is
incorporated as a chain transfer agent, rather than as a comonomer, then the copolymer ﬂuorescence is insensitive to the local pH.
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absorption spectra at pH 5, 6, and 7 (Figure 1c-1e) reveals an
additional feature at around 485 nm, which corresponds to the
peak assigned to deprotonated Nile Blue within reverse micelles
reported by Das et al.41 However, in the spectrum recorded at
pH 7 a 640 nm peak is still visible, despite the strong light
scattering caused by vesicle formation (Figure 1e). This latter
feature corresponds to protonated Nile Blue, and was also
observed for the reverse micelle system described by Das et
al.41 The residual protonated Nile Blue is responsible for the
absence of any color change in the copolymer solutions (Figure
1a). In contrast, the λmax is reduced much more gradually from
around 600 nm at pH 5 to around 500 nm at pH 7 for both
PMPC25PDPA59NBC0.08 and PMPC25PDPA62NBM0.13 (see
Figure 1b). Inspection of the absorption spectra obtained for
these two copolymers show one dominant peak that shifts
between pH 5 and 7 (see Figure 1c-1e). In this case, there is no
residual peak from the protonated dye and the color shift is
much more pronounced for these two copolymer solutions (see
Figure 1a).
Toxicity of Dye-Labeled PMPC-PDPA Block Copoly-
mers. Vesicle biocompatibility studies of the three Nile Blue-
labeled PMPC-PDPA diblock copolymers were performed on
human dermal ﬁbroblasts (Figure S13 of the SI). High cell
viabilities were obtained, which is consistent with those
previously observed for PMPC-PDPA diblock copolymers.33,36
Use of Dye-Labeled PMPC-PDPA Block Copolymers
for Monitoring Hypoxic Regions in Tumor Models. The
sensitivity of the three Nile Blue-labeled PMPC-PDPA diblock
copolymers to the local pH within a multicell tumor spheroid
(MCTS) model was evaluated. Given its marked gradients in
pH,53 oxygen, and glucose concentration between the outer and
inner regions,54,55 the MCTS model is generally considered to
be a superior mimic for the physiological changes that occur in
avascular tumor tissues compared to cell monolayers.56 Figure 2
conﬁrms that the pH-sensitivity of PMPC25PDPA59NBC0.08
and PMPC25PDPA62NBM0.13 enables the local pH to be
conveniently monitored within MCTS tissue. Culturing of
MCTS for 5, 10, or 15 days allowed tissue growth, thus
increasing the area of the hypoxic region over time. For
comparative assessment of the probes, immunostaining of
glucose transporter 1 (Glut-1) in MCTS was performed as a
positive control (see Figure 2b). This approach is well
established for ﬁxed (dead) tissue, but is not applicable for
live tissue. Glut-1 expression has been reported to correlate well
with tumor hypoxia both in vivo57 and in MCTS models.58 In
the latter case, its use results in a gradient of increasing intensity
toward the center of the spheroid. For copolymer-treated
MCTS, the growth of the hypoxic region could be directly
visualized by a change in the color of the stained spheroid
tumor tissue from purple (physiological pH) to blue (low pH),
as indicated by the digital photographs shown in Figure 1a. In
addition, the boundary between low pH and physiological pH
within the spheroid mass could be accurately determined using
optical microscopy (see Figure 2b).
Both PMPC25PDPA62NBM0.13 and PMPC25PDPA59NBC0.08
probes were able to detect pH changes within the living tissue
(i.e., between the inner and outer edges) over time in a similar
manner to the positive control performed using Glut-1 on ﬁxed
tissue (see Figure 3). It is worth emphasizing that, although
PMPC-PDPA diblock copolymer vesicles are rapidly uptaken
by most cell types,33,36 a signiﬁcant fraction will nevertheless
remain within the interstitial tissue. When the PDPA block
becomes highly protonated below approximately pH 6.0, vesicle
dissociation occurs. The resulting individual copolymer chains
are uptaken to a lesser extent than the vesicles, and a relatively
large fraction of the former species does not enter cells in
hypoxic (acidic) tissue. Although the copolymer chains acquire
cationic character and in principle may bind electrostatically to
negatively charged cell membranes, internalization does not
occur unless the local concentration of cationic charge density
becomes high enough to disrupt the membrane.59,60 The
relatively small size of the copolymer chains61 also makes
endocytosis unlikely, and this process is further hindered by the
acidic environment.62 Therefore, these new biocompatible Nile
Blue-based copolymer probes enable the diﬀerential interstitial
pH of live spheroids to be monitored continuously and
noninvasively in real time, as opposed to the indirect approach
required for ﬁxed tissue based on Glut-1. This is important
because, although the interstitial pH decreases, the intracellular
pH remains at physiological levels in tumoral masses.25,26,63
Importantly, no diﬀerential staining was observed when the
MCTS model was treated with PMPC25−PDPA61-NB0.13
(Figure 2). This is consistent with our observation of a
minimal spectral shift for this copolymer over the pH range of
interest (Figure 1a,c).
Dye-Labeled PMPC-PDPA Copolymers As Fluorescent
Probes of Intracellular Environments. Figure 4a shows the
ﬂuorescence intensity as a function of solution pH. For all
copolymers, the emission intensity increases at higher pH, but
the onset of this stronger ﬂuorescence occurs between pH 4
and 5 for PMPC25PDPA59NBC0.08, whereas it is observed at
around pH 6.5 (i.e., close to the PDPA pKa) for the other two
copolymers. Deprotonation of the PDPA block provides a
hydrophobic environment, which is known to increase the
quantum yield of Nile Blue.43,45 The 700 nm/670 nm emission
ratio is also pH-dependent (see Figure 4b). This parameter
decreases for PMPC25PDPA61NB0.13 at around the pKa of the
PDPA block. A hypsochromic shift from 660 to 575 nm in the
emission spectra (Figure S12 of the SI) is consistent with
formation of the deprotonated form of Nile Blue in the
hydrophobic vesicle membranes formed by the neutral PDPA
blocks.45 This dominates the emission spectra due to the
increased quantum yield, although the absorption spectra
shows that there is still a signiﬁcant amount of protonated dye
(see Figure 1).
Similar behavior is observed for PMPC25PDPA59NBC0.08 but
the shift is only 40 nm in this case (see Figure S12 of the SI).
PMPC25PDPA62NBM0.13 has a maximum emission ratio at pH
6.5; this is attributed to the additional band in the emission
spectrum of NBM (Figure S8 of the SI), which enhances the
ﬂuorescence intensity at 700 nm.
However, in situ formation of the vesicle membranes
provides a hydrophobic environment that shifts the maximum
emission wavelength, which oﬀsets this eﬀect. This leads to an
overall reduction in emission ratio above pH 6.5 (see Figure
4b). Nevertheless, the observed shift in emission due to the
more hydrophobic local environment is signiﬁcantly less for
NBM and NBC than for NB. PMPC-PDPA vesicles are readily
uptaken by cells and become uniformly distributed within
membrane organelles.33,36 As shown in Figure 4c, exposure of
cells to both PMPC25PDPA59NBC0.08 and PMPC25PDPA62-
NBM0.13 led to colocalization of the 700 nm signal with
lysosomes (pH < 5). In addition, early endosomes could be
detected using the 670 nm signal (pH 6.0−6.5). The higher
relative ratio observed at around pH 6.5 of PMPC25PDPA62-
NBM0.13 allows other intracellular regions to be visualized, as
Journal of the American Chemical Society Article
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shown in the merged image. PMPC25PDPA61NB0.13 could not
be detected at 700 nm (Figure 4c), due to the relatively weak
ﬂuorescence of this polymer at this wavelength. Instead, the
670 nm signal was uniformly distributed within the cell,
regardless of the pH of the subcellular localization. This
indicates the uniform localization of this copolymer, as
previously observed with rhodamine-labeled copolymers.36
■ CONCLUSIONS
In summary, Nile Blue-based vinyl monomers act as spin-traps,
retarding living radical polymerizations. Nevertheless, labeled
polymers can be prepared by adding the dye label at high
polymer conversion, albeit with relatively low labeling
eﬃciency. Such Nile Blue labels can be incorporated into
PMPC-PDPA diblock copolymers, which then self-assemble to
form biocompatible vesicles at physiological pH. These
copolymers exhibit variable absorption and ﬂuorescence
emission depending on their local pH. Importantly, they can
be utilized for imaging pH gradients within live tumor models,
as well as for probing intracellular microenvironments. This
principle is summarized in Figure 5. The advantage of this new
probe is that the nature of the copolymer determines its
biological fate, while the ﬂuorophore reports on the local pH.
In contrast, the cellular uptake and intracellular localization of
small molecule probes is mainly dictated by their hydrophilic/
hydrophobic balance. Thus, uptake of hydrophobic molecules
by cells is usually rather slow and ineﬃcient.64−68 In view of the
wide range of pathological conditions that are characterized by
a pH imbalance, such copolymers are expected to have a broad
range of applications. Finally, such copolymer vesicles can also
encapsulate both hydrophilic and hydrophobic drugs36,69 which
suggests their potential use as theranostic agents.
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